Valiant Laboratories Limited (NSE:VALIANTLAB)
58.00
+0.31 (0.54%)
Feb 2, 2026, 3:29 PM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 3.15 billion as of February 2, 2026. Its market cap has decreased by -28.37% in one year.
Market Cap
3.15B
Enterprise Value
3.06B
Revenue
1.86B
Ranking
n/a
PE Ratio
56.21
Stock Price
58.00
Market Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 3.15B, a decrease of -57.44%. That is a compound annual growth rate of -30.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 1, 2026 | 3.13B | -17.59% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 11.29B |
| Ind-Swift Laboratories | 9.26B |
| Sakar Healthcare | 8.70B |
| Sigachi Industries | 7.62B |
| Bafna Pharmaceuticals | 2.77B |
| Nectar Lifesciences | 2.63B |
| Brooks Laboratories | 1.81B |
| Alpa Laboratories | 1.43B |